The FDA’s green light for a Phase II trial (JSKN003-202) of JSKN003 accelerates efforts to address platinum-resistant ovarian ...

Mayo Clinic is the first U.S. health system to treat a case of breast cancer with a new radioactive treatment, it announced Friday, Aug. 1. The medicine contains actinium-225, a radioactive element.

When people think of breast cancer, they often picture obvious warning signs like lumps or noticeable changes in breast shape ...